Verified ProfileEN

JILIN ZIXIN SHEN GONG TANG BIOLOGICAL TECHNOLOGY CO.,LTD.

Order verification — $199

Manufacturing · Manufacture of proprietary Chinese medicines

Verification dossier

JILIN ZIXIN SHEN GONG TANG BIOLOGICAL TECHNOLOGY CO.,LTD. is a Chinese company based in Tonghua, Jilin. The company operates in the manufacture of proprietary chinese medicines sector, within the broader manufacturing industry. Established 2017, the company has been operating for 9 years.

Sinolinks tracks JILIN ZIXIN SHEN GONG TANG BIOLOGICAL TECHNOLOGY CO.,LTD. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Research, technical consulting, and technology transfer for plant extracts, health foods, pharmaceuticals, and chemical products (excluding hazardous chemicals); production and sales of plant extracts and chemical products (excluding hazardous chemicals); import and export trade of self-operated products. Research, development, production, sales, and online operation of local specialty products, beverages (solid and other), and confectionery; cultivation of Chinese medicinal materials; retail of Chinese medicinal materials; primary processing and wholesale/retail of edible agricultural products. (Subject to approval for licensed items).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review